Skip to main content
F

Formosa Laboratories, Inc. — Investor Relations & Filings

Ticker · 4746 TW Manufacturing
Filings indexed 1,858 across all filing types
Latest filing 2025-06-20 Regulatory Filings
Country TW Taiwan
Listing TW 4746

About Formosa Laboratories, Inc.

https://www.formosalab.com

Formosa Laboratories, Inc. is a Contract Development and Manufacturing Organization (CDMO) specializing in the development and production of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. The company provides integrated services ranging from process development and custom synthesis to large-scale commercial manufacturing. Its core product portfolio includes UV-filters, Vitamin D derivatives, and polymers such as cholesterol and phosphate binders. Formosa Laboratories offers specialized expertise in Antibody-Drug Conjugates (ADCs) and injectable manufacturing, including cytotoxic and freeze-dried products. Maintaining high quality standards, its facilities are cGMP-compliant and have been successfully inspected by the US FDA, TFDA, EDQM, and PMDA. The company serves a global clientele, providing one-stop solutions for complex chemical synthesis, fermentation, and peptide production.

Recent filings

Filing Released Lang Actions
公告本公司新任法人董事指派代表人
Regulatory Filings
2025-06-20 Chinese
公告本公司114年股東常會全面改選董事(含獨立董事) 當選名單
Regulatory Filings
2025-06-20 Chinese
公告本公司114年股東常會重要決議事項
Regulatory Filings
2025-06-20 Chinese
公司治理組織架構
Regulatory Filings
2025-06-19 Chinese
114年06月內部人持股轉讓(事前)
Regulatory Filings
2025-06-09 Chinese
114年05月內部人持股異動(事後)
Regulatory Filings
2025-06-06 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.